United Therapeutics (UTHR) Tops Q1 EPS by 19c, Miss on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $511.72 -0.73%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
PLNH, SPRU, BBGI, More
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
PLNH, SPRU, BBGI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.76, $0.19 better than the analyst estimate of $3.57. Revenue for the quarter came in at $389.2 million versus the consensus estimate of $401.94 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Grocery Outlet Holding Corp. (GO) Tops Q2 EPS by 8c, Offers Guidance
- Forward Industries, Inc. (FWDI) Misses Q2 EPS by 83c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
